Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666983 | SCV000791365 | uncertain significance | Glycogen storage disease, type V | 2017-05-09 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000666983 | SCV002018989 | uncertain significance | Glycogen storage disease, type V | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000666983 | SCV003439883 | uncertain significance | Glycogen storage disease, type V | 2022-07-03 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 161 of the PYGM protein (p.Arg161Cys). This variant is present in population databases (rs200038732, gnomAD 0.002%). This missense change has been observed in individual(s) with glycogen storage disease type V (PMID: 17404776). ClinVar contains an entry for this variant (Variation ID: 551832). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV000666983 | SCV004207247 | likely pathogenic | Glycogen storage disease, type V | 2023-08-02 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000666983 | SCV005684404 | likely pathogenic | Glycogen storage disease, type V | 2024-03-06 | criteria provided, single submitter | clinical testing |